Education
About Us
Working with TipRanks
Follow Us
Frank Fischer Insider Profile
4 Followers
Frank Fischer, Director at Nevro Corp, holds 593.35K shares in NeuroPace (Ticker: NPCE), holds 57.50K shares in Nevro Corp (Ticker: NVRO), holds 6.21K shares in Tenon Medical, Inc. (Ticker: TNON).
Frank Fischer Nevro Corp (NVRO)Director
Nevro Corp (NVRO)
Director
Not Ranked
Frank Fischer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Frank Fischer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Frank Fischer
Frank Fischer's Trading History
Nevro Corp
Apr 02, 2024
―
Uninformative Buy
―
$335.80K
NeuroPace
Dec 23, 2025
Director
Uninformative Buy
23.74K
$9.16M
Tenon Medical, Inc.
May 24, 2023
Director
Uninformative Buy
10.06K
$5.90K
List of latest transactions for each holding click on a transaction to see Frank Fischer's performance on stock
You May Also Like
Frank Fischer insider profile FAQ
What is the percentage of profitable transactions made by Frank Fischer?
The percentage of profitable transactions made by Frank Fischer is ―.
What is the average return per transaction made by Frank Fischer?
The average return per transaction made by Frank Fischer is ―.
What stocks does Frank Fischer hold?
Frank Fischer holds: NVRO, NPCE, TNON stocks.
What was Frank Fischer’s latest transaction?
Frank Fischer latest transaction was an Uninformative Buy of $23.74K.
What was Frank Fischer's most profitable transaction?
Frank Fischer’s most profitable transaction was an Informative Buy of NPCE stock on April 23, 2021. The return on the trade was -67.20%.
What is Frank Fischer's role in Nevro Corp?
Frank Fischer's role in Nevro Corp is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.